Kesler Norman & Wride LLC Increases Stake in CorVel Co. (NASDAQ:CRVL)

Kesler Norman & Wride LLC boosted its stake in CorVel Co. (NASDAQ:CRVL) by 295.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,904 shares of the business services provider’s stock after buying an additional 5,158 shares during the period. Kesler Norman & Wride LLC’s holdings in CorVel were worth $769,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of CRVL. SkyView Investment Advisors LLC boosted its position in shares of CorVel by 1.6% during the third quarter. SkyView Investment Advisors LLC now owns 4,351 shares of the business services provider’s stock valued at $1,422,000 after purchasing an additional 67 shares in the last quarter. Fifth Third Bancorp boosted its holdings in shares of CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock valued at $36,000 after buying an additional 101 shares in the last quarter. Sanctuary Advisors LLC grew its position in shares of CorVel by 4.6% in the 3rd quarter. Sanctuary Advisors LLC now owns 2,848 shares of the business services provider’s stock worth $931,000 after buying an additional 124 shares during the period. Franklin Resources Inc. grew its position in shares of CorVel by 9.9% in the 3rd quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider’s stock worth $614,000 after buying an additional 173 shares during the period. Finally, US Bancorp DE increased its stake in shares of CorVel by 225.4% in the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock worth $43,000 after acquiring an additional 266 shares in the last quarter. 51.36% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CorVel news, Director Steven J. Hamerslag sold 10,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total transaction of $1,234,800.00. Following the transaction, the director now owns 314,000 shares in the company, valued at approximately $38,772,720. This represents a 3.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the sale, the director now owns 118,213 shares of the company’s stock, valued at $13,758,811.07. This represents a 7.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 32,200 shares of company stock valued at $3,824,115. Insiders own 47.57% of the company’s stock.

CorVel Stock Down 1.7 %

CorVel stock opened at $111.50 on Thursday. The stock’s 50 day moving average is $112.42 and its 200 day moving average is $114.73. The company has a market capitalization of $5.73 billion, a P/E ratio of 65.59 and a beta of 1.06. CorVel Co. has a twelve month low of $76.20 and a twelve month high of $128.61.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a research note on Thursday, March 13th.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.